Brief: Pure Biologics To Get Subsidy For Drug Development
Jan 31 (Reuters) - Pure Biologics SA PUR1.WA :
* SAYS ITS PROJECT FOR DRUG DEVELOPMENT WILL GET 30.1
MILLION
ZLOTY SUBSIDY FROM EUROPEAN FUNDS
* SAYS TOTAL VALUE OF THE PROJECT IS 39.9 MILLION ZLOTYS,
REMAINING 9.8 MILLION ZLOTYS COMPANY PLANS TO FINANCE WITH
FUTURE SHARE ISSUES
Source text for Eikon: ID:nEM7Cv6nga
Further company coverage: PUR1.WA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects